Shenzhen Hepalink Pharmaceutical Co. Ltd. | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.85 |
Market Cap |
CNY26.08 B |
Shares Outstanding |
1.25 B |
Public Float |
235.92 M |
Address |
No. 21 Langshan Road Shenzhen Guangdong 518057 China |
Employees | - |
Website | http://www.hepalink.com |
Updated | 07/08/2019 |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is engaged in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products, including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China. |